US › Healthcare

Nuwellis Inc (NUWE)

US · Healthcare · Medical Devices

$1.88+16.77%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$2.4M

Revenue YoY

+26.2%

Net profit

$-4.3M

Profit YoY

-43.9%

EPS

$-73.15

EPS estimate

$-35.00

Net margin

-180.5%

EPS came in at -73.15 against a street estimate of -35.00 — a miss of 109.0%.

Key statistics

Market cap

$148,443

P/E

0.0

Forward P/E

0.0

P/B

0.24

Book value

$35.34

EPS (TTM)

$47.25

52-week high

$235.20

52-week low

$1.34

50-day MA

$8.72

200-day MA

$54.37

Beta

0.29

Analyst view

Analysts rate Nuwellis Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $11.00.

Shareholding

Insiders

0.01%

Institutions

1.66%

Largest institutional holders

Fund	Stake
Armistice Capital, LLC	1.85%
Geode Capital Management, LLC	0.35%
Tower Research Capital LLC	0.04%
Citigroup Inc	0.04%
SBI Securities Co Ltd	0.00%
UBS Group AG	0.00%
Caitong International Asset Management Co., Limited.	0.00%
Ankerstar Wealth, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Nuwellis Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.